Our customer service representatives are available 24 hours a day, from Monday to Sunday.
The skin microbiome—the diverse community of microorganisms residing on the skin surface—has emerged as a central paradigm in modern cosmetic science. A balanced, diverse microbiome is increasingly recognized as essential for healthy skin function, while dysbiosis (microbial imbalance) is associated with conditions ranging from acne and atopic dermatitis to dandruff and premature aging. At Alfa Chemistry, we provide cutting-edge in vitro microbiome and micro-ecology testing services that enable cosmetic brands to substantiate microbiome-friendly, prebiotic, postbiotic, and micro-ecology claims with rigorous scientific evidence.
Our microbiome testing platform spans from high-throughput 16S rRNA community profiling to functional co-culture assays and biofilm analysis, providing a comprehensive toolkit for evaluating how cosmetic ingredients and formulations interact with the skin's microbial ecosystem. All services are conducted in our laboratory facilities using validated protocols.
Our microbiome and micro-ecology testing services support a wide range of cosmetic product types and claims, including but not limited to:
Understanding the composition and diversity of the skin microbial community is the foundation of microbiome-directed cosmetic development. Our 16S ribosomal RNA gene sequencing service provides a high-resolution view of bacterial community structure on the skin surface, enabling the evaluation of how cosmetic products influence microbial diversity, richness, and community composition. This data supports claims related to microbiome-friendly, microbiome-balancing, and skin flora-respecting product attributes.
| Test Method | Description and Application |
|---|---|
| DNA Extraction from Skin Swab Samples | Optimized DNA extraction protocols for low-biomass skin swab samples, ensuring representative recovery of microbial genomic DNA from both Gram-positive and Gram-negative bacteria present on the skin surface. |
| 16S rRNA Gene PCR Amplification | Targeted amplification of hypervariable regions (V3-V4 or V1-V3) of the bacterial 16S rRNA gene using universal primers, generating amplicon libraries suitable for high-throughput sequencing. |
| High-Throughput Sequencing | Next-generation sequencing platform to generate millions of high-quality reads per sample, providing the sequencing depth necessary for robust community analysis. |
| Bioinformatics Analysis and Reporting | Comprehensive bioinformatics pipeline including quality filtering, operational taxonomic unit (OTU) clustering, taxonomic assignment against reference databases, alpha diversity analysis (Shannon, Chao1 indices), beta diversity analysis (PCoA, NMDS), and differential abundance testing. Delivers clear visualizations and statistical comparisons suitable for efficacy claim substantiation. |
The growing interest in prebiotic and postbiotic cosmetic ingredients has created a need for robust in vitro models that can demonstrate selective effects on skin-relevant microorganisms. Our co-culture and metabolomics-based assays provide mechanistic evidence that cosmetic ingredients promote beneficial skin bacteria while inhibiting pathogenic species, supporting prebiotic, postbiotic, and micro-ecology regulation claims.
| Test Method | Description and Application |
|---|---|
| Co-Culture System (S. epidermidis / C. acnes) | In vitro co-culture model simulating the competitive interaction between beneficial Staphylococcus epidermidis and opportunistic Cutibacterium acnes. The assay quantifies the selective growth promotion or inhibition of each species following treatment with test articles, providing direct evidence for prebiotic selectivity and micro-ecology balancing effects. |
| Microbial Metabolomics Profiling | Analysis of microbial metabolite production in culture supernatants using LC-MS/MS or GC-MS, including short-chain fatty acids, organic acids, and antimicrobial peptides. Metabolomic changes induced by test articles reveal the functional impact of cosmetic ingredients on skin microbial metabolism. |
| Selective Growth Promotion Assay | Quantitative assessment of growth kinetics of individual skin-relevant bacterial strains (beneficial and pathogenic) in the presence of test articles. Dose-response curves demonstrate prebiotic effects at physiologically relevant concentrations. |
| Postbiotic Activity Characterization | Evaluation of the biological activity of postbiotic ingredients (microbial lysates, ferments, cell-free supernatants) on skin cell models, including assessment of anti-inflammatory, antioxidant, and barrier-enhancing effects in keratinocyte and fibroblast cultures. |
Biofilm formation by skin-associated microorganisms is a critical factor in the persistence and recurrence of conditions such as acne, dandruff, and chronic wound infections. Microorganisms within biofilms are significantly more resistant to antimicrobial agents and host immune defenses than their planktonic counterparts. Our biofilm testing services evaluate the ability of cosmetic ingredients and formulations to prevent biofilm formation or disrupt established biofilms, providing powerful evidence for anti-acne, anti-biofilm, and deep-cleansing claims.
| Test Method | Description and Application |
|---|---|
| Crystal Violet Biofilm Quantification | Standardized microtiter plate-based assay using crystal violet staining to quantify total biofilm biomass. The assay measures both biofilm prevention (test article added before biofilm formation) and biofilm disruption (test article applied to pre-formed biofilm), providing dose-response data for biofilm clearance efficacy. |
| Confocal Laser Scanning Microscopy (CLSM) | High-resolution three-dimensional visualization of biofilm architecture using live/dead fluorescent staining and confocal microscopy. Provides qualitative and semi-quantitative assessment of biofilm thickness, viability, and structural integrity before and after treatment. |
| Biofilm Viability Assay | Metabolic activity-based measurement (e.g., resazurin reduction) of viable cells within biofilms, complementing the biomass quantification from crystal violet staining to distinguish between biofilm removal and biofilm killing effects. |
| Multi-Species Biofilm Model | Advanced biofilm models incorporating multiple skin-relevant bacterial species to better simulate the complexity of in vivo skin biofilms. Evaluates the impact of test articles on mixed-species biofilm communities. |
A: Prebiotic ingredients are substrates that selectively promote the growth or activity of beneficial skin microorganisms. Postbiotic ingredients are non-viable microbial products or metabolic byproducts (such as ferments, lysates, or cell-free supernatants) that confer a benefit to the skin. Probiotic ingredients contain live microorganisms; however, the use of live probiotics in cosmetics is subject to strict regulatory and stability considerations. Our testing services are designed to support prebiotic and postbiotic claims through in vitro efficacy validation.
A: 16S rRNA sequencing provides quantitative data on changes in microbial community structure following product use. Key metrics include maintenance or increase in microbial diversity (alpha diversity), preservation of a healthy community composition, and selective modulation of specific bacterial taxa. These data can support claims such as microbiome-friendly, respects skin flora, or balances skin microbiome.
A: For 16S rRNA community analysis, skin swab samples collected using standardized sampling kits are required. Swabs are typically collected from defined skin sites before and after product application according to a study protocol. For in vitro co-culture and biofilm assays, we work with your cosmetic ingredients or finished formulations directly.
A: Yes. Our biofilm testing protocols include separate assay arms for biofilm prevention (test article added at the time of bacterial inoculation, before biofilm formation) and biofilm disruption (test article applied to mature, pre-formed biofilms). This distinction is important for positioning products as either preventive (daily use to prevent biofilm accumulation) or therapeutic (targeted treatment to clear existing biofilm).
A: Timelines vary by study scope. A standard 16S rRNA sequencing project with bioinformatics analysis typically requires 4–6 weeks from sample receipt to final report. Co-culture and biofilm assays can be completed within 2–4 weeks. Larger multi-endpoint programs may require 6–10 weeks. We provide detailed timelines during the project proposal phase.
If you have any questions, please contact us. You will get a satisfactory answer.
